Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network

EMBO Journal

Volumn 17, Issue 20, 1998, Pages 5948-5963

  Tzahar, Eldad ^a   Moyer, James D ^b   Waterman, Hadassa ^a   Barbacci, Elsa G ^b   Bao, Jing ^a   Levkowitz, Gil ^a   Shelly, Maya ^a   Strano, Sabrina ^a   Pinkas Kramarski, Ronit ^a   Pierce, Jacalyn H ^c   Andrews, Glenn C ^b   Yarden, Yosef ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

DNA virus; Growth factor; Oncogene; Signal transduction; Tyrosine kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; LIGAND BINDING; MOUSE; NONHUMAN; ONCOGENE NEU; ONCOVIRINAE; POXVIRUS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMALLPOX; VACCINIA VIRUS; VIRUS PATHOGENESIS; VIRUS VIRULENCE;

ANIMALS; CELLS, CULTURED; DIMERIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; POXVIRIDAE; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; SIGNAL TRANSDUCTION;

EID: 0032531927     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.20.5948     Document Type: Article

References (69)

1. Alimandi,M., Romano,A., Curia,M.C., Muraro,R., Fedi,P., Aaronson,S.A., Di Fiore,P.P. and Kraus,M.H. (1995) Cooperative signaling of ErbB-3 and ErhB-2 in neoplastic transformation of human mammary carcinoma cells. Oncogene, 15, 1813-1821.
2. Alimandi,M., Wang,L.-M., Bottaro,D., Lee,C.-C., Angera,K., Frankel,M., Fedi,P., Tang,F., Tang,C., Lippman,M. and Pierce,J.H. (1997) Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. EMBO J., 16, 5608-5617.
3. Alroy,I. and Yarden,Y. (1997) The ErbB signaling network in embryogenes is and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett., 410, 83-86.
4. Barbacci,E.G., Guarino,B.C., Stroh,J.G., Singleton,D.H., Rosnack,K.J., Moyer,J.D. and Andrews,G.C. (1995) The structural basis for the specificity of epidermal growth factor and heregulin binding. J. Biol. Chem., 270, 9585-9589.
5. Bargmann,C.I., Hung,M.C. and Weinberg,R.A. (1986) Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell, 45, 649-657.
6. Baulida,J., Kraus,M.H., Alimandi,M., Di Fiore,P.P. and Carpenter,G. (1996) All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J. Biol. Chem., 271, 5251-5257.
7. Beerli,R.R. and Hynes,N.E. (1996) Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J. Biol. Chem., 271, 6071-6076.
8. Blomquist,M.D., Hunt,L.T. and Baker,W.C. (1984) Vaccinia virus 19kilodalton protein: Relationship to several mammalian proteins,including two growth factors. Proc. Natl Acad. Sci. USA, 81, 73637367.
9. Brown,J.P., Twardzik,D.R., Marquardt,H. and Todaro,G.J. (1985) Vaccinia virus encodes a peptidc homologous to epidermal growth factor and transforming growth factor Nature, 313, 491-492.
10. Buller,R.M.L. and Pulumho,G.J. (1991) Pox virus pathogenesis. Microbiol. Rev., 55, 80-122.
11. Burden,S. and Yarden,Y. (1997) Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron, 18, 847-855.
12. Chang,W., Upton,C., Hu,S.-L., Purchio,A.F. and McFadden,G. (1987) The genome of sheep fibroma virus, a tumorigenic poxvirus,contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor. Mol. Cell. Biol., 7, 535-540.
13. Chen,R.-H., Sarnecki,C. and Blenis,J. (1992) Nuclear localization and regulation of erk- and RSK-encoded protein kinases. Mol. Cell. Biol., 12, 915-927.
14. Chen,X. et al. (1996) An immunological approach refais biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4. J. Biol Chem., 271, 7620-7629.
15. Cohen,B.D., Kiener,P.K., Green,J.M., Foy,L., Fell,H.P. and Zhang,K. (1996) The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH-3T3 cells. J. Biol. Chem., 271, 30897-30903.
16. Culouscou,J.M., Carlton,G.W. and Aruffo,A.(1995) HER4 receptor activation and phosphorylation of She proteins by recombinant heregulin-Fc fusion proteins. J. Biol. Chem., 270, 12857-12863.
17. Davis,R.J. (1994) MAPKs: a new JNK expands the group. Trends Biochem. Sci., 19, 470-473.
18. Downward,J., Yarden,Y., Mayes,E., Scrace,G., Totty,N., Stockwell,P., Ullrich,A., Schlessinger,J. and Waterfield,M.D. (1984) Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature, 307, 521-527.
19. Ebner,R. and Derynck,R. (1991) Epidermal growth factor and transforming growth factor-a: differential intracellular routing and processing of ligand-receptor complexes. Cell Regul., 2, 599-612.
20. Galcheva-Gargova,Z., Theroux,S.J. and Davis,R.J. (1995) The epidermal growth factor receptor is covalently linked to ubiquitin. Oncogene, 11, 2649-2655.
21. Glenney,J.R., Chen,W.S., Lazar,C.S., Walton,G.M., Zokas,L.M., Rosenfeld,M.G. and Gill,G.N. (1988) Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies. Cell, 52, 675-684.
22. Guy,P.M., Platko,J.V., Cantley,L.C., Cerione,R.A. and Carraway,K.L. (1994) Insect cell-expressed p180ErbB3 possesses an impaired tyrosine kinase activity. Proc. Natl Acad. Sci. USA, 91, 8132-8136.
23. Hicke,L. (1997) Ubiquitin-dependent internalization and down-regulation of plasma membrane proteins. FASEB J., 11, 1215-1226.
24. Karunagaran,D., Tzahar,E., Liu,N., Wen,D. and Yarden,Y. (1995) Neu differentiation factor inhibits EGF binding: a model for trans-regulation within the ErbB family of receptor tyrosine kinases. J. Biol. Chem., 270, 9982-9990.
25. Karunagaran,D., Tzahar,E., Beerli,R.R., Chen,X., Graus-Porta,D., Ratzkin,B.J., Seger,R., Hynes,N.E. and Yarden,Y. (1996) ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J., 15, 254-264.
26. King,D.. Fields,C. and Fields,G. (1990) A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int. J. Pept. Protein Res., 36, 255-266.
27. Kokai,Y., Myers,J.N., Wada,T., Brown,V.I., LeVea,C.M., Davis,J.G., Dobashi,K. and Greene,M.I. (1989) Synergistic interaction of p185cneu and the EGF receptor leads to transformation of rodent fibroblasts. Cell, 58, 287-292.
28. Kornfeld,K. (1997) Vulval development in Caenorhabditis elegans. Trends Genet., 13, 55-61.
29. Kotwal,G.J. and Moss,B. (1988) Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature, 335, 176-181.
30. Kraus,M.H., Popescu,N.C., Amsbaugh,S.C. and King,R.C. (1987) Expression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell line by different molecular mechanisms. EMBO J., 6, 605-610.
31. Lee,K.F., Simon,H., Chen,H., Bates,B., Hung,M.C. and Hauser,C. (1995) Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature, 378, 394-398.
32. Lenormand,P., Sardet,C., Pages,G., L'Allemain,G., Brunet,A. and Pouyssegur,J. (1993) Growth factors induce nuclear translocation of MAP kinase (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell Biol., 122, 1079-1088.
33. Levkowitz,G., Klapper,L.N., Tzahar,E., Freywald,A., Sela,M. and Yarden,Y. (1996) Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. Oncogens, 12, 1117-1125.
34. Lin,X.-Z., Capooraco,G., Chang,P.-Y., Ke,X.-H. and Tam,J.P. (1988) Synthesis of a biological active tumor growth factor from the predicted DNA of Shope Fibroma Virus. Biochemistry, 27, 5640-5645.
35. Lin,Y.-Z., Ke,X.-H. and Tam,J.P. (1990) Growth inhibition by vaccinia growth factor. J. Biol. Chem., 265, 18884-18890.
36. Lin,Y.-Z., Ke,X.-H. and Tam,J.P. (1991) Synthesis and structure-activity study of Myxoma virus growth facton Biochemistry, 30, 3310-3314.
37. Marikovsky,M., Lavi,S., . Pinkas-Kramarski.R.. Karunagaran,D., Liu,N., Wen,D. and Yarden,Y. (1995) ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes. Oncogene, 10, 1403-1411.
38. Marshall,C.J. (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80, 179-185.
39. McFadden,G., Graham,K. and Barry,M. (1996) New strategies of immune modulation by DNA viruses. Tranplant. Proc., 28, 2085-2088.
40. Mosman,T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
41. Moyer,J.D., Barbacci,E.G., Iwata,K.K., Arnold,L., Roman,B., Cunningham,A., DiOrio,C., Doty,J., Morin,M.J., Moyer,M.P., Neveu,M., Pollack,V.A., Rustilnik,L.R., Reynolds,M.M., Sloan,D., Theleman,A. and Miller,P. (1997) Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res., 57, 4834-4848.
42. Obom,K.M. and Pogo,G.B.T. (1988) Characterization of the transformation properties of Shope fibroma virus. Virus Res., 9, 33-48.
43. Opgenorth,A., Strayer,D., Upton,C. and McFadden,G. (1992) Deletion of the growth factor gene related to EGF and TGFα reduces virulence of malignant rabbit fibroma virus. Virology, 186, 175-191.
44. Opgenorth,A., Nation,N., Graham,K. and McFadde,G. (1993) Transforming growth factor alpha,shope fibroma virus factor and vaccinia growth factor can replace myxoma growth factor in the induction of myxomatosis in rabbits. Virology, 192, 701-709.
45. Pinkas-Kramarski,R. et al. (1996) Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J., 15, 2452-2467.
46. Pinkas-Kramarski,R. et al. (1998) The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin. Oncogene, 16, 1249-1258.
47. Reddy,C.C., Niyogi,S.K., Wells,A., Wiley,H.S. and Lauffenburger,D.A. (1996) Engineering epidermal growth factor for enhanced mitogenic potency. Nature Biotech., 14, 1696-1699.
48. Riese,D.J., van Raaij,T.M., Plowman,G.D., Andrews,G.C. and Stern,D.F. (1995) The cellular response to neuregulins is governed by complex interactions of the ErbB receptor family. Mol. Cell. Biol., 15, 5770- 5776.
49. Riese,D.J., Kim,E.D., Elenius,K., BuckIey,S., Klagsbrun,M., Plowman,G.D. and Stern,D.F. (1996) The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor and amphireguiin to Neu, ErbB-3 and ErbB-4. J. Biol. Chem., 271, 20047-20052.
50. Salomon,D.S., Brandt,R., Ciardiello,F. and Normanno,N. (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19, 183-232.
51. Shelly,M. et al. (1998) Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J. Biol. Chem., 273, 10496-10505.
52. Slamon,D.J. et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712.
53. Smith,C.A., Davis,T., Anderson,D., Solam,L., Beckman,M.P., Jerzy,R., Dower,S.K., Cosman,D. and Goodwin,R.G. (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science, 248, 1019-1023.
54. Sorkin,A. and Waters,C.M. (1993) Endocytosis of growth factor receptors. Bioessays, 15, 375-382.
55. Sproul,E.E., Metzgar,R.S. and Grace,J.T.J. (1963) The pathogenesis of Yaba virus-induced histiocytomas in primates. Cancer Res., 23, 671-675.
56. Stroobant,P., Rice,A.P., Gullick,W.J., Cheng,D.J., Kerr,I.M. and Waterfield,M.D. (1985) Purification and characterization of vaccinia virus growth factor. Cell, 42, 383-393.
57. Toyoda,H., Komursaki,T., Uchida,D., Takayama,Y., Isobe,T., Okuyama,T. and Hanada,K. (1995) Epiregulin, a novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J. Biol. Chem., 270, 7495-7500.
58. Tzahar,E. and Yarden,Y. (1998) The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands. BBA Rev. Cancer, 1377,M25-M37.
59. Tzahar,E., Waterman,H., Chen,X., Levkowitz,G., Karunagaran,D., Lavi,S., Ratzkin,B.J. and Yarden,Y. (1996) A hierarchical network of inter-receptor interactions determines signal transduction by NDF/ neuregulin and EGF. Mol. Cell. Biol., 16, 5276-5287.
60. Tzahar,E. et al. (1997) Bivalency of EGF-Iike ligands drives the ErbB signaling network. EMBO J., 16, 4938-4950.
61. Ullrich,A., Coussens,L., Hayflick,J.S., Dull,T.J., Gray,A., Tam,A.W., Lee,J., Yarden,Y., Libermann,T.A., Schlessinger,J., Downward,J., Mayes,E.L.V., Whittle,N., Waterfield,M.D. and Seeburg,P.H. (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells,Nature, 309, 418-425.
62. Upton,C., Macen,J.L. and McFadden,G. (1987) Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor α. J. Virol., 61, 1271-1275.
63. van der Geer,P., Hunter,T. and Lindberg,R.A. (1994) Receptor protein- tyrosine kinases and their signal transduction pathways. Ann. Rev. Cell Biol., 10, 251-337.
64. Vieira,A.V., Lamaze,C. and Schmid,S.L. (1996) Control of EGF receptor signaling by clathrin-mediated endocytosis. Science, 274, 2086-2088.
65. Wallasch,C., Weiss,F.U., Niederfellner,G., Jallal,B., Issing,W. and Ullrich,A. (1995) Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J., 14, 4267-4275.
66. Waterman,H., Sabanai,I., Geiger,B. and Yarden,Y. (1998) Alternative intracellular routing of ErbB receptors may determine signaling potency. J. Biol. Chem., 273, 13819-13827.
67. Wells,A., Welsh,J.B., Lazar,C.S., Wiley,H.S., Gill,G.N. and Rosenfeld,M.G. (1990) Ligand-induced transformation by a noninternalizing epidermal growth factor receptoc Science, 247, 962-964.
68. Yung,Y. et al. (1997) Detection of ERK activation by a novel monoclonal antibody. FEBS J., 408, 292-296.
69. Zhang,K., Sun,J., Liu,N., Wen,D., Chang,D., Thomason,A. and Yoshinaga,S.K. (1996) Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J. Biol. Chem., 271, 3884-3890.